For patients with ER negative tumours, the MMP-2 TT genotype was associated with poor survival (2/8 patients alive at end of study, 25%) compared to the CC or CT genotypes (59/70, 84%; p < 0.001). The gene discussed is MMP2; the disease is neoplasm.